e-learning
resources
Vienna 2009
Monday, 14.09.2009
Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Nontuberculous mycobacterial adenitis: the diagnostic value of interferon-γ release assays
F. Mouchet, K. Schepers, V. Verscheure, V. Toppet, J. Levy, F. Mascart (Brussels, Belgium)
Source:
Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections
Session:
Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections
Session type:
Thematic Poster Session
Number:
2461
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Mouchet, K. Schepers, V. Verscheure, V. Toppet, J. Levy, F. Mascart (Brussels, Belgium). Nontuberculous mycobacterial adenitis: the diagnostic value of interferon-γ release assays. Eur Respir J 2009; 34: Suppl. 53, 2461
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Clinical evaluation of a diagnostic method of tuberculosis infection, QuantiFERON TB-2G, for active tuberculosis and nontuberculous mycobacteriosis
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006
Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics
Source: Eur Respir J 2006; 28: 1204-1210
Year: 2006
Treatment of pulmonary NTM infection: can it be done?
Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge
Year: 2007
Discordance between TSTs and IFN-γ release assays: the role of NTM and the relevance of mycobacterial sensitins
Source: Eur Respir J 2010; 36: 215-216
Year: 2010
Discordance between TSTs and IFN-γ release assays: the role of NTM and the relevance of mycobacterial sensitins
Source: Eur Respir J 2010; 36: 214-215
Year: 2010
Nontuberculous mycobacteriosis - from diagnosis to therapy
Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities
Year: 2005
Pathogenicity of NTM: new developments
Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge
Year: 2007
Comparision of line probe assay and conventional methos for detection of mycobacteria other than tuberculosis (MOTT) strains from patients suferring from pulmonary tuberculosis
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016
Clinical evaluation of QuantiFERON TB -2g test in patients with nontuberculous mycobacterial disease
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Late Breaking Abstract - Use of non-tuberculous mycobacteria (NTM) specific antigens to detect NTM infection
Source: International Congress 2019 – The microbiome: novel data across respiratory diseases
Year: 2019
Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis
Source: Eur Respir J 2010; 35: 338-342
Year: 2010
Identification of nontuberculous mycobacteria using GenoType® Mycobacterium CM
Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis
Year: 2010
Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response
Source: Eur Respir J 2004; 23: 741-746
Year: 2004
Simultaneous infection with nontuberculous and tuberculous mycobacteria
Source: Annual Congress 2007 - Clinical tuberculosis
Year: 2007
Glycopeptidolipids for evaluating the role of non-tuberculous mycobacteria in latent tuberculosis infection diagnosis
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013
Clinical evaluation of interferon-gamma release assay (IGRA) in patients with nontuberculous mycobacterial disease
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012
The specificity of a new skin test – Diaskintest (recombinant protein CFP10-ESAT6) in patients with sarcoidosis and non-tuberculous pulmonary diseases
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011
Pulmonary non-tuberculous mycobacterial infection: 889 cases
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019
Exclusion of active Mycobacterium tuberculosis complex infection with the T-SPOTTM.TB assay
Source: Eur Respir J 2007; 29: 605-607
Year: 2007
Non-tuberculous mycobacteria (NTM) in bronchiectasis - a difficult management problem
Source: Eur Respir J 2003; 22: Suppl. 45, 515s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept